

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.85070382 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.85070382 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.68048742 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.68048742 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 6.42764560 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.94526693 |
| 7 | glyoxylate metabolic process (GO:0046487) | 5.80056271 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66925838 |
| 9 | cysteine metabolic process (GO:0006534) | 5.64347068 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 5.28864156 |
| 11 | lysine catabolic process (GO:0006554) | 5.28496781 |
| 12 | lysine metabolic process (GO:0006553) | 5.28496781 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.20465779 |
| 14 | low-density lipoprotein particle clearance (GO:0034383) | 5.18172521 |
| 15 | tryptophan catabolic process (GO:0006569) | 5.16030754 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 5.16030754 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 5.16030754 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14580126 |
| 19 | bile acid biosynthetic process (GO:0006699) | 5.13974609 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.95626791 |
| 21 | triglyceride catabolic process (GO:0019433) | 4.95331108 |
| 22 | amino-acid betaine metabolic process (GO:0006577) | 4.95202263 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.90442394 |
| 24 | cellular ketone body metabolic process (GO:0046950) | 4.74289641 |
| 25 | neutral lipid catabolic process (GO:0046461) | 4.71749260 |
| 26 | acylglycerol catabolic process (GO:0046464) | 4.71749260 |
| 27 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.67602727 |
| 28 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.67602727 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.67463019 |
| 30 | short-chain fatty acid metabolic process (GO:0046459) | 4.65384780 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.52860275 |
| 32 | serine family amino acid biosynthetic process (GO:0009070) | 4.49573111 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 4.42677806 |
| 34 | negative regulation of sterol transport (GO:0032372) | 4.42677806 |
| 35 | serine family amino acid metabolic process (GO:0009069) | 4.40033670 |
| 36 | alpha-amino acid catabolic process (GO:1901606) | 4.38107671 |
| 37 | biotin metabolic process (GO:0006768) | 4.38039980 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.36369292 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 4.35973146 |
| 40 | bile acid metabolic process (GO:0008206) | 4.35734669 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.35652857 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.34856139 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.34807590 |
| 44 | fatty acid beta-oxidation (GO:0006635) | 4.29107741 |
| 45 | fatty acid homeostasis (GO:0055089) | 4.28935295 |
| 46 | cellular modified amino acid catabolic process (GO:0042219) | 4.28486456 |
| 47 | ethanol oxidation (GO:0006069) | 4.26361194 |
| 48 | regulation of complement activation (GO:0030449) | 4.21969127 |
| 49 | * very long-chain fatty acid metabolic process (GO:0000038) | 4.21256331 |
| 50 | urea metabolic process (GO:0019627) | 4.21072472 |
| 51 | urea cycle (GO:0000050) | 4.21072472 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 4.20866298 |
| 53 | regulation of sequestering of triglyceride (GO:0010889) | 4.20198769 |
| 54 | glutamate metabolic process (GO:0006536) | 4.19712488 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 4.18149491 |
| 56 | polyketide metabolic process (GO:0030638) | 4.17377588 |
| 57 | doxorubicin metabolic process (GO:0044598) | 4.17377588 |
| 58 | daunorubicin metabolic process (GO:0044597) | 4.17377588 |
| 59 | ketone body metabolic process (GO:1902224) | 4.14837907 |
| 60 | protein carboxylation (GO:0018214) | 4.14460039 |
| 61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.14460039 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 4.12518238 |
| 63 | macromolecular complex remodeling (GO:0034367) | 4.12518238 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 4.12518238 |
| 65 | carnitine metabolic process (GO:0009437) | 4.11883110 |
| 66 | diacylglycerol metabolic process (GO:0046339) | 4.09825650 |
| 67 | L-serine metabolic process (GO:0006563) | 4.09380062 |
| 68 | fatty acid oxidation (GO:0019395) | 4.07025046 |
| 69 | glycine metabolic process (GO:0006544) | 4.05228440 |
| 70 | lipid oxidation (GO:0034440) | 4.03026884 |
| 71 | tyrosine metabolic process (GO:0006570) | 4.02906612 |
| 72 | drug catabolic process (GO:0042737) | 4.01283547 |
| 73 | acetyl-CoA metabolic process (GO:0006084) | 3.99476641 |
| 74 | regulation of fibrinolysis (GO:0051917) | 3.99321432 |
| 75 | drug transmembrane transport (GO:0006855) | 3.98304045 |
| 76 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.98192298 |
| 77 | fatty acid catabolic process (GO:0009062) | 3.96758773 |
| 78 | nitrogen cycle metabolic process (GO:0071941) | 3.91590761 |
| 79 | monocarboxylic acid catabolic process (GO:0072329) | 3.91454199 |
| 80 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91219240 |
| 81 | phospholipid efflux (GO:0033700) | 3.90943591 |
| 82 | organic acid catabolic process (GO:0016054) | 3.89479362 |
| 83 | carboxylic acid catabolic process (GO:0046395) | 3.89479362 |
| 84 | NADH metabolic process (GO:0006734) | 3.88166966 |
| 85 | complement activation, alternative pathway (GO:0006957) | 3.85168290 |
| 86 | urate metabolic process (GO:0046415) | 3.84758269 |
| 87 | response to nitrosative stress (GO:0051409) | 3.77546937 |
| 88 | amine catabolic process (GO:0009310) | 3.76345174 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 3.76345174 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76198065 |
| 91 | linoleic acid metabolic process (GO:0043651) | 3.75110892 |
| 92 | cellular glucuronidation (GO:0052695) | 3.73857236 |
| 93 | coenzyme catabolic process (GO:0009109) | 3.73496471 |
| 94 | triglyceride homeostasis (GO:0070328) | 3.72324210 |
| 95 | acylglycerol homeostasis (GO:0055090) | 3.72324210 |
| 96 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71756742 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 3.71466630 |
| 98 | * acyl-CoA metabolic process (GO:0006637) | 3.70455841 |
| 99 | * thioester metabolic process (GO:0035383) | 3.70455841 |
| 100 | regulation of cholesterol metabolic process (GO:0090181) | 3.67510085 |
| 101 | fibrinolysis (GO:0042730) | 3.66099918 |
| 102 | primary alcohol metabolic process (GO:0034308) | 3.65677079 |
| 103 | glycerolipid catabolic process (GO:0046503) | 3.64932476 |
| 104 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.63681155 |
| 105 | indolalkylamine metabolic process (GO:0006586) | 3.62716646 |
| 106 | benzene-containing compound metabolic process (GO:0042537) | 3.60284087 |
| 107 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.59185092 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 3.58348094 |
| 109 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56934590 |
| 110 | cholesterol efflux (GO:0033344) | 3.55825615 |
| 111 | drug transport (GO:0015893) | 3.54143174 |
| 112 | arginine metabolic process (GO:0006525) | 3.53342196 |
| 113 | plasma lipoprotein particle assembly (GO:0034377) | 3.50732858 |
| 114 | flavonoid metabolic process (GO:0009812) | 3.49817284 |
| 115 | regulation of protein activation cascade (GO:2000257) | 3.48761410 |
| 116 | exogenous drug catabolic process (GO:0042738) | 3.48256142 |
| 117 | regulation of plasminogen activation (GO:0010755) | 3.48143004 |
| 118 | drug metabolic process (GO:0017144) | 3.46942442 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.46924763 |
| 120 | primary alcohol catabolic process (GO:0034310) | 3.46660996 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.45284629 |
| 122 | aldehyde catabolic process (GO:0046185) | 3.42751951 |
| 123 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.42437072 |
| 124 | acute-phase response (GO:0006953) | 3.40471629 |
| 125 | ethanol metabolic process (GO:0006067) | 3.39479193 |
| 126 | positive regulation of lipid catabolic process (GO:0050996) | 3.37708485 |
| 127 | uronic acid metabolic process (GO:0006063) | 3.36294032 |
| 128 | glucuronate metabolic process (GO:0019585) | 3.36294032 |
| 129 | oxaloacetate metabolic process (GO:0006107) | 3.34988280 |
| 130 | neutral lipid biosynthetic process (GO:0046460) | 3.33763350 |
| 131 | acylglycerol biosynthetic process (GO:0046463) | 3.33763350 |
| 132 | thioester biosynthetic process (GO:0035384) | 3.28707944 |
| 133 | acyl-CoA biosynthetic process (GO:0071616) | 3.28707944 |
| 134 | intestinal cholesterol absorption (GO:0030299) | 3.27775193 |
| 135 | triglyceride biosynthetic process (GO:0019432) | 3.27536877 |
| 136 | triglyceride metabolic process (GO:0006641) | 3.27014895 |
| 137 | epoxygenase P450 pathway (GO:0019373) | 3.25139203 |
| 138 | positive regulation of lipid storage (GO:0010884) | 3.24819674 |
| 139 | xenobiotic catabolic process (GO:0042178) | 3.24427246 |
| 140 | regulation of triglyceride metabolic process (GO:0090207) | 3.19574048 |
| 141 | acylglycerol metabolic process (GO:0006639) | 3.16609116 |
| 142 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.15430355 |
| 143 | oxidative demethylation (GO:0070989) | 3.14905476 |
| 144 | regulation of cholesterol storage (GO:0010885) | 3.14894646 |
| 145 | response to phenylpropanoid (GO:0080184) | 3.11675575 |
| 146 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.10984290 |
| 147 | neutral lipid metabolic process (GO:0006638) | 3.10815085 |
| 148 | regulation of lipoprotein particle clearance (GO:0010984) | 3.05500841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.57594895 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.48780076 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.90760583 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.78496487 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.50328091 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.46640419 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.00760684 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.48405460 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.15301613 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.09915290 |
| 11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.45482576 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42732802 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.42660896 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23304271 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16850285 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6413129 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.97413271 |
| 18 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87255943 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.83933869 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79556618 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69832371 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65954161 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59951310 |
| 24 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43907392 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43759659 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38408573 |
| 27 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37232040 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32876289 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31810842 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22787594 |
| 31 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21814925 |
| 32 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20893860 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16145342 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14261326 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12800358 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12658984 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12577089 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10485561 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08825451 |
| 40 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05583959 |
| 41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04687394 |
| 42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03697341 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.03476577 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02939937 |
| 45 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99668557 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98755905 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98276740 |
| 48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98089122 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97525566 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93652836 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92843819 |
| 52 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91528624 |
| 53 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90635016 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90536012 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90100573 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88795305 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87873781 |
| 58 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87257483 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86835763 |
| 60 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.85752390 |
| 61 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85657530 |
| 62 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84970233 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83990886 |
| 64 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.83885877 |
| 65 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83366485 |
| 66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82734729 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82566969 |
| 68 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.82050072 |
| 69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.81903158 |
| 70 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81023025 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80429754 |
| 72 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.79751463 |
| 73 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.79678660 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79644591 |
| 75 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.78860349 |
| 76 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77797642 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77777700 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77766874 |
| 79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77735083 |
| 80 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77599175 |
| 81 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.77454110 |
| 82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77337559 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76531433 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75948281 |
| 85 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.75931363 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75328405 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74768983 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.74430765 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72800663 |
| 90 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.72118905 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.71792427 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71643177 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.71058281 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.70361813 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.69691820 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69435251 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67926719 |
| 98 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.66450480 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.66304886 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 0.65567321 |
| 101 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.64703263 |
| 102 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.64580291 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64571535 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64571535 |
| 105 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.62477609 |
| 106 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.62039529 |
| 107 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.61648840 |
| 108 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.61177709 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60048733 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59482165 |
| 111 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.59134005 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58970485 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57902950 |
| 114 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.57261426 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.56451727 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.55867147 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.55853196 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.55853196 |
| 119 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55386739 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54407385 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54221399 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.53830978 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.52927163 |
| 124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52325825 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52066703 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51023622 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50873338 |
| 128 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.50870946 |
| 129 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.50003442 |
| 130 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49785927 |
| 131 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.49708213 |
| 132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49240147 |
| 133 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.49204513 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47350318 |
| 135 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.46949136 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.46223495 |
| 137 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.45812083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17326901 |
| 2 | MP0005360_urolithiasis | 6.90784360 |
| 3 | MP0005365_abnormal_bile_salt | 5.57368774 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.52976653 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.57862709 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.61657461 |
| 7 | MP0003252_abnormal_bile_duct | 3.33793701 |
| 8 | MP0005332_abnormal_amino_acid | 3.23134875 |
| 9 | MP0009840_abnormal_foam_cell | 3.17850793 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.14996298 |
| 11 | MP0005083_abnormal_biliary_tract | 2.72333271 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.70545360 |
| 13 | MP0003195_calcinosis | 2.66194552 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.36278324 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.32695432 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.15584646 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.03675038 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.99446046 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.99132296 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.98599708 |
| 21 | MP0003011_delayed_dark_adaptation | 1.97187836 |
| 22 | MP0005375_adipose_tissue_phenotype | 1.89427729 |
| 23 | MP0005451_abnormal_body_composition | 1.81389100 |
| 24 | MP0000609_abnormal_liver_physiology | 1.76535506 |
| 25 | MP0000751_myopathy | 1.69389600 |
| 26 | MP0002254_reproductive_system_inflammat | 1.68680141 |
| 27 | MP0008438_abnormal_cutaneous_collagen | 1.67711997 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.65425900 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.64877291 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.57388829 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.50855684 |
| 32 | MP0003186_abnormal_redox_activity | 1.49432295 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48021723 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.47723432 |
| 35 | MP0002970_abnormal_white_adipose | 1.47230580 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.43691358 |
| 37 | MP0005334_abnormal_fat_pad | 1.42391512 |
| 38 | MP0005535_abnormal_body_temperature | 1.42332121 |
| 39 | MP0003646_muscle_fatigue | 1.40017700 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 1.39035498 |
| 41 | MP0003868_abnormal_feces_composition | 1.35201028 |
| 42 | MP0009115_abnormal_fat_cell | 1.33406566 |
| 43 | MP0003959_abnormal_lean_body | 1.24927448 |
| 44 | MP0005275_abnormal_skin_tensile | 1.21519210 |
| 45 | MP0001764_abnormal_homeostasis | 1.21481574 |
| 46 | MP0004043_abnormal_pH_regulation | 1.20967937 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.19396127 |
| 48 | MP0003136_yellow_coat_color | 1.18026427 |
| 49 | MP0003690_abnormal_glial_cell | 1.16467591 |
| 50 | MP0002796_impaired_skin_barrier | 1.15016329 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.13951677 |
| 52 | MP0005647_abnormal_sex_gland | 1.05870561 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.05082007 |
| 54 | MP0000749_muscle_degeneration | 1.03803740 |
| 55 | MP0004233_abnormal_muscle_weight | 1.02744824 |
| 56 | MP0009053_abnormal_anal_canal | 1.01675156 |
| 57 | MP0006138_congestive_heart_failure | 1.01433441 |
| 58 | MP0000566_synostosis | 0.98964222 |
| 59 | MP0001756_abnormal_urination | 0.96222945 |
| 60 | MP0009384_cardiac_valve_regurgitation | 0.95675267 |
| 61 | MP0005503_abnormal_tendon_morphology | 0.95412635 |
| 62 | MP0005448_abnormal_energy_balance | 0.94688724 |
| 63 | MP0005646_abnormal_pituitary_gland | 0.93948976 |
| 64 | MP0000579_abnormal_nail_morphology | 0.93560689 |
| 65 | MP0005452_abnormal_adipose_tissue | 0.90986645 |
| 66 | MP0002098_abnormal_vibrissa_morphology | 0.89088044 |
| 67 | MP0005330_cardiomyopathy | 0.88468715 |
| 68 | MP0000598_abnormal_liver_morphology | 0.86934636 |
| 69 | MP0003329_amyloid_beta_deposits | 0.84669544 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.84449049 |
| 71 | MP0002249_abnormal_larynx_morphology | 0.84215075 |
| 72 | MP0000604_amyloidosis | 0.83797120 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 0.83044767 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 0.79999499 |
| 75 | MP0000759_abnormal_skeletal_muscle | 0.78706206 |
| 76 | MP0009764_decreased_sensitivity_to | 0.77626524 |
| 77 | MP0002282_abnormal_trachea_morphology | 0.77553424 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.76235992 |
| 79 | MP0005408_hypopigmentation | 0.74747282 |
| 80 | MP0004087_abnormal_muscle_fiber | 0.74647498 |
| 81 | MP0003879_abnormal_hair_cell | 0.72387403 |
| 82 | MP0002108_abnormal_muscle_morphology | 0.71907974 |
| 83 | MP0004036_abnormal_muscle_relaxation | 0.71594438 |
| 84 | MP0003953_abnormal_hormone_level | 0.71577297 |
| 85 | MP0002090_abnormal_vision | 0.71389994 |
| 86 | MP0004130_abnormal_muscle_cell | 0.69821560 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.69409407 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.68030407 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.68023200 |
| 90 | MP0001544_abnormal_cardiovascular_syste | 0.67399232 |
| 91 | MP0005385_cardiovascular_system_phenoty | 0.67399232 |
| 92 | MP0000647_abnormal_sebaceous_gland | 0.67292686 |
| 93 | MP0002269_muscular_atrophy | 0.66614452 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.66168544 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.65322889 |
| 96 | MP0009697_abnormal_copulation | 0.64413134 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.64054130 |
| 98 | MP0004885_abnormal_endolymph | 0.64050325 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.63742991 |
| 100 | MP0005165_increased_susceptibility_to | 0.61322014 |
| 101 | MP0000343_altered_response_to | 0.60754480 |
| 102 | MP0005501_abnormal_skin_physiology | 0.60684131 |
| 103 | MP0009379_abnormal_foot_pigmentation | 0.60214721 |
| 104 | MP0009763_increased_sensitivity_to | 0.60192487 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.60066728 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.60059707 |
| 107 | MP0003828_pulmonary_edema | 0.59989397 |
| 108 | MP0000377_abnormal_hair_follicle | 0.59924715 |
| 109 | MP0005620_abnormal_muscle_contractility | 0.59832993 |
| 110 | MP0002106_abnormal_muscle_physiology | 0.59413769 |
| 111 | MP0004381_abnormal_hair_follicle | 0.59076766 |
| 112 | MP0003279_aneurysm | 0.58768787 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.58059217 |
| 114 | MP0005369_muscle_phenotype | 0.57540323 |
| 115 | MP0005164_abnormal_response_to | 0.56825321 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.56092732 |
| 117 | MP0002971_abnormal_brown_adipose | 0.55171069 |
| 118 | MP0005645_abnormal_hypothalamus_physiol | 0.54022753 |
| 119 | MP0010368_abnormal_lymphatic_system | 0.53965611 |
| 120 | MP0000467_abnormal_esophagus_morphology | 0.52946545 |
| 121 | MP0000537_abnormal_urethra_morphology | 0.52449826 |
| 122 | MP0002127_abnormal_cardiovascular_syste | 0.52359633 |
| 123 | MP0005670_abnormal_white_adipose | 0.52297794 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.51684097 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.51227774 |
| 126 | MP0001881_abnormal_mammary_gland | 0.49579725 |
| 127 | MP0000383_abnormal_hair_follicle | 0.49425771 |
| 128 | MP0001340_abnormal_eyelid_morphology | 0.48878755 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.48502361 |
| 130 | MP0005395_other_phenotype | 0.47663672 |
| 131 | MP0004858_abnormal_nervous_system | 0.47422041 |
| 132 | MP0003075_altered_response_to | 0.47237913 |
| 133 | MP0002168_other_aberrant_phenotype | 0.46124120 |
| 134 | MP0005220_abnormal_exocrine_pancreas | 0.45902775 |
| 135 | MP0003300_gastrointestinal_ulcer | 0.45520544 |
| 136 | MP0004272_abnormal_basement_membrane | 0.45294320 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.45067730 |
| 138 | MP0008469_abnormal_protein_level | 0.45054206 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.44149352 |
| 140 | MP0003878_abnormal_ear_physiology | 0.43839027 |
| 141 | MP0005377_hearing/vestibular/ear_phenot | 0.43839027 |
| 142 | MP0001958_emphysema | 0.43206652 |
| 143 | MP0005266_abnormal_metabolism | 0.41623201 |
| 144 | MP0010030_abnormal_orbit_morphology | 0.40067613 |
| 145 | MP0006035_abnormal_mitochondrial_morpho | 0.39951310 |
| 146 | MP0002092_abnormal_eye_morphology | 0.39256093 |
| 147 | MP0004883_abnormal_blood_vessel | 0.39251471 |
| 148 | MP0003942_abnormal_urinary_system | 0.38996069 |
| 149 | MP0001661_extended_life_span | 0.38831254 |
| 150 | MP0000462_abnormal_digestive_system | 0.37748774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.63321967 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.01358383 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.00372475 |
| 4 | Xanthomatosis (HP:0000991) | 5.92883968 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.58065460 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.25467049 |
| 7 | Hyperglycinuria (HP:0003108) | 5.14230910 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 5.06184563 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.06184563 |
| 10 | Hyperglycinemia (HP:0002154) | 4.88505986 |
| 11 | Hyperammonemia (HP:0001987) | 4.86656301 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.77147277 |
| 13 | Ketosis (HP:0001946) | 4.70921190 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.55155411 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33487873 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.17493076 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.06420806 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.06330776 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.02260000 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.97637865 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.97159083 |
| 22 | Delayed CNS myelination (HP:0002188) | 3.85065556 |
| 23 | Ketoacidosis (HP:0001993) | 3.78272571 |
| 24 | Epidermoid cyst (HP:0200040) | 3.76843416 |
| 25 | Gout (HP:0001997) | 3.70491050 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66844787 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.64798186 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.59683664 |
| 29 | Increased serum pyruvate (HP:0003542) | 3.53417356 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.49835280 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.40693509 |
| 32 | Dicarboxylic aciduria (HP:0003215) | 3.38279354 |
| 33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.38279354 |
| 34 | Myoglobinuria (HP:0002913) | 3.34144136 |
| 35 | Joint hemorrhage (HP:0005261) | 3.29834939 |
| 36 | Fat malabsorption (HP:0002630) | 3.22186635 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 3.18437200 |
| 38 | Oligomenorrhea (HP:0000876) | 3.16848105 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.16400582 |
| 40 | Metabolic acidosis (HP:0001942) | 3.12352872 |
| 41 | Hypercholesterolemia (HP:0003124) | 3.10291983 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09431909 |
| 43 | Mitral stenosis (HP:0001718) | 3.06007524 |
| 44 | Spastic diplegia (HP:0001264) | 3.02905252 |
| 45 | Abnormality of glycolysis (HP:0004366) | 2.99993584 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.98541326 |
| 47 | Reduced antithrombin III activity (HP:0001976) | 2.97107770 |
| 48 | Exercise-induced myalgia (HP:0003738) | 2.95242380 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.91421327 |
| 50 | Complement deficiency (HP:0004431) | 2.84143408 |
| 51 | Lethargy (HP:0001254) | 2.82671015 |
| 52 | Proximal tubulopathy (HP:0000114) | 2.80902100 |
| 53 | Malnutrition (HP:0004395) | 2.77448887 |
| 54 | Vascular calcification (HP:0004934) | 2.76705570 |
| 55 | Glomerulonephritis (HP:0000099) | 2.70902088 |
| 56 | Hyperbilirubinemia (HP:0002904) | 2.67981986 |
| 57 | Alkalosis (HP:0001948) | 2.63814743 |
| 58 | Increased purine levels (HP:0004368) | 2.62707761 |
| 59 | Hyperuricemia (HP:0002149) | 2.62707761 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.61410150 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.60918017 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.58335917 |
| 63 | Glycosuria (HP:0003076) | 2.53540378 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.53540378 |
| 65 | Vertebral compression fractures (HP:0002953) | 2.51728204 |
| 66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47240181 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47240181 |
| 68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47240181 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.42331671 |
| 70 | Hepatic necrosis (HP:0002605) | 2.42064542 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.41654862 |
| 72 | Rickets (HP:0002748) | 2.40742367 |
| 73 | Enlarged kidneys (HP:0000105) | 2.40335584 |
| 74 | Vomiting (HP:0002013) | 2.39672975 |
| 75 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38741034 |
| 76 | Nemaline bodies (HP:0003798) | 2.38065021 |
| 77 | Cerebral edema (HP:0002181) | 2.34982557 |
| 78 | Irritability (HP:0000737) | 2.34914424 |
| 79 | Confusion (HP:0001289) | 2.34085834 |
| 80 | Steatorrhea (HP:0002570) | 2.32861808 |
| 81 | Beaking of vertebral bodies (HP:0004568) | 2.32243789 |
| 82 | Hypokalemic alkalosis (HP:0001949) | 2.31660470 |
| 83 | Hypoglycemic seizures (HP:0002173) | 2.31616783 |
| 84 | Protrusio acetabuli (HP:0003179) | 2.31471482 |
| 85 | Acanthosis nigricans (HP:0000956) | 2.30430275 |
| 86 | Muscle fiber inclusion bodies (HP:0100299) | 2.27817206 |
| 87 | Mesangial abnormality (HP:0001966) | 2.27239970 |
| 88 | Hypertriglyceridemia (HP:0002155) | 2.26416304 |
| 89 | Purpura (HP:0000979) | 2.25981961 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 2.24650415 |
| 91 | Hydroxyprolinuria (HP:0003080) | 2.24650415 |
| 92 | Back pain (HP:0003418) | 2.24175837 |
| 93 | Late onset (HP:0003584) | 2.23366165 |
| 94 | Increased muscle lipid content (HP:0009058) | 2.22433392 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22379783 |
| 96 | Mucopolysacchariduria (HP:0008155) | 2.22379783 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21272149 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21272149 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21272149 |
| 100 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.19380387 |
| 101 | Sensorimotor neuropathy (HP:0007141) | 2.19270678 |
| 102 | Respiratory distress (HP:0002098) | 2.18507220 |
| 103 | Abnormality of carpal bone ossification (HP:0006257) | 2.16491510 |
| 104 | Asymmetric septal hypertrophy (HP:0001670) | 2.14619534 |
| 105 | Neonatal onset (HP:0003623) | 2.07399081 |
| 106 | 3-Methylglutaconic aciduria (HP:0003535) | 2.05799564 |
| 107 | Esophageal varix (HP:0002040) | 2.05522779 |
| 108 | Type 1 muscle fiber predominance (HP:0003803) | 2.04383647 |
| 109 | Pancreatitis (HP:0001733) | 2.04226461 |
| 110 | Hyperactive renin-angiotensin system (HP:0000841) | 2.03048702 |
| 111 | Amyloidosis (HP:0011034) | 2.02243535 |
| 112 | Vacuolated lymphocytes (HP:0001922) | 2.01954995 |
| 113 | Skin nodule (HP:0200036) | 2.01575180 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.99912144 |
| 115 | Methylmalonic aciduria (HP:0012120) | 1.97621185 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 1.96521655 |
| 117 | Hyperphosphaturia (HP:0003109) | 1.95654327 |
| 118 | Abnormal biliary tract physiology (HP:0012439) | 1.95435886 |
| 119 | Bile duct proliferation (HP:0001408) | 1.95435886 |
| 120 | Myocardial infarction (HP:0001658) | 1.93088709 |
| 121 | Nausea (HP:0002018) | 1.91849982 |
| 122 | Abnormal delivery (HP:0001787) | 1.91586037 |
| 123 | Abnormality of complement system (HP:0005339) | 1.90648468 |
| 124 | Dysostosis multiplex (HP:0000943) | 1.89197451 |
| 125 | Acute encephalopathy (HP:0006846) | 1.88148670 |
| 126 | Increased circulating renin level (HP:0000848) | 1.87531184 |
| 127 | Abnormal pupillary function (HP:0007686) | 1.85246132 |
| 128 | Renal cortical cysts (HP:0000803) | 1.85205599 |
| 129 | Nephrolithiasis (HP:0000787) | 1.84718174 |
| 130 | Turricephaly (HP:0000262) | 1.84649790 |
| 131 | Metabolic alkalosis (HP:0200114) | 1.82958875 |
| 132 | Opisthotonus (HP:0002179) | 1.82945529 |
| 133 | Brushfield spots (HP:0001088) | 1.82416076 |
| 134 | Gingival bleeding (HP:0000225) | 1.81944943 |
| 135 | Abnormal tarsal ossification (HP:0008369) | 1.80878188 |
| 136 | Abnormal urine output (HP:0012590) | 1.79413379 |
| 137 | Gonadal dysgenesis (HP:0000133) | 1.78943607 |
| 138 | Spontaneous abortion (HP:0005268) | 1.78236257 |
| 139 | Epiphyseal stippling (HP:0010655) | 1.77671432 |
| 140 | Ulnar deviation of the wrist (HP:0003049) | 1.77428825 |
| 141 | Neurofibrillary tangles (HP:0002185) | 1.76118358 |
| 142 | Muscle stiffness (HP:0003552) | 1.75895157 |
| 143 | Cholelithiasis (HP:0001081) | 1.75660507 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74899428 |
| 145 | Hypophosphatemic rickets (HP:0004912) | 1.74352842 |
| 146 | Abnormal urine phosphate concentration (HP:0012599) | 1.69588715 |
| 147 | Tachypnea (HP:0002789) | 1.67580056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.33822744 |
| 2 | SIK1 | 4.34048454 |
| 3 | WNK3 | 3.01740263 |
| 4 | OBSCN | 2.82004675 |
| 5 | WNK4 | 2.79564668 |
| 6 | PKN2 | 2.77248657 |
| 7 | MYLK | 2.75896685 |
| 8 | FGFR4 | 2.72123845 |
| 9 | TESK1 | 2.69281340 |
| 10 | ERN1 | 2.62549982 |
| 11 | LIMK1 | 2.59646178 |
| 12 | MUSK | 2.54496961 |
| 13 | OXSR1 | 2.52264875 |
| 14 | TRIB3 | 2.38424599 |
| 15 | ARAF | 2.37079254 |
| 16 | EPHB1 | 2.34765463 |
| 17 | MAPK15 | 2.30051422 |
| 18 | MAPKAPK3 | 2.16898589 |
| 19 | LMTK2 | 2.10067970 |
| 20 | ICK | 2.07732892 |
| 21 | STK39 | 1.96206551 |
| 22 | PTK6 | 1.94239802 |
| 23 | FGFR2 | 1.92733994 |
| 24 | MST1R | 1.90982657 |
| 25 | PIM2 | 1.90622414 |
| 26 | LATS1 | 1.89112575 |
| 27 | EPHB2 | 1.86475457 |
| 28 | ERBB4 | 1.75051155 |
| 29 | PIK3CG | 1.57847671 |
| 30 | STK16 | 1.52377345 |
| 31 | LRRK2 | 1.48983162 |
| 32 | TBK1 | 1.48821309 |
| 33 | FLT3 | 1.46179864 |
| 34 | STK38L | 1.44977322 |
| 35 | NUAK1 | 1.33870482 |
| 36 | ERBB2 | 1.30037364 |
| 37 | MAP3K12 | 1.28972394 |
| 38 | MAPK11 | 1.23141868 |
| 39 | MAP2K2 | 1.22584030 |
| 40 | INSRR | 1.17184596 |
| 41 | MAP3K10 | 1.17078313 |
| 42 | MET | 1.14478320 |
| 43 | TTN | 1.14297940 |
| 44 | PDK3 | 1.09994405 |
| 45 | PDK4 | 1.09994405 |
| 46 | GSK3A | 1.07727924 |
| 47 | DAPK3 | 1.04497176 |
| 48 | DYRK1B | 1.03607675 |
| 49 | PHKG2 | 0.99730528 |
| 50 | PHKG1 | 0.99730528 |
| 51 | MAP3K7 | 0.96127975 |
| 52 | SGK223 | 0.94000557 |
| 53 | SGK494 | 0.94000557 |
| 54 | ABL2 | 0.91931359 |
| 55 | MAP3K1 | 0.89213441 |
| 56 | TIE1 | 0.86856327 |
| 57 | RIPK1 | 0.86802422 |
| 58 | IRAK1 | 0.86286026 |
| 59 | CDK6 | 0.86072432 |
| 60 | PRKAA2 | 0.85367095 |
| 61 | MAP3K3 | 0.82574675 |
| 62 | IRAK3 | 0.81205588 |
| 63 | MAPK4 | 0.78721138 |
| 64 | GRK6 | 0.78176438 |
| 65 | DAPK2 | 0.78028797 |
| 66 | FER | 0.77548291 |
| 67 | NEK9 | 0.76826463 |
| 68 | CAMK1 | 0.76554140 |
| 69 | PTK2 | 0.75943258 |
| 70 | PAK3 | 0.73198540 |
| 71 | CSNK1G1 | 0.72615307 |
| 72 | PDGFRA | 0.70284839 |
| 73 | MAPK12 | 0.69128425 |
| 74 | RPS6KC1 | 0.68091235 |
| 75 | RPS6KL1 | 0.68091235 |
| 76 | MAP3K11 | 0.67765631 |
| 77 | CAMK1D | 0.66578327 |
| 78 | TGFBR2 | 0.66353102 |
| 79 | EPHA4 | 0.66051480 |
| 80 | PRKCZ | 0.65542228 |
| 81 | EPHA3 | 0.64913909 |
| 82 | PINK1 | 0.64308190 |
| 83 | PDK2 | 0.63959694 |
| 84 | FGFR1 | 0.62661767 |
| 85 | TGFBR1 | 0.62136494 |
| 86 | IRAK2 | 0.61146529 |
| 87 | PAK4 | 0.58966211 |
| 88 | GRK1 | 0.58853247 |
| 89 | MAP2K1 | 0.58789926 |
| 90 | GRK5 | 0.57664635 |
| 91 | PBK | 0.57192806 |
| 92 | IGF1R | 0.57110792 |
| 93 | VRK2 | 0.56834768 |
| 94 | DAPK1 | 0.56601037 |
| 95 | EEF2K | 0.56323294 |
| 96 | NME2 | 0.55788242 |
| 97 | RPS6KA2 | 0.55712544 |
| 98 | RPS6KA6 | 0.55324545 |
| 99 | MAP2K6 | 0.53968890 |
| 100 | GRK7 | 0.53539820 |
| 101 | MAP3K6 | 0.52264564 |
| 102 | PAK2 | 0.52225142 |
| 103 | PRKACA | 0.51974870 |
| 104 | CAMK2G | 0.50920376 |
| 105 | PRKACG | 0.50788989 |
| 106 | PRKG1 | 0.50277618 |
| 107 | CDK8 | 0.47830929 |
| 108 | PRKD2 | 0.47011542 |
| 109 | DDR2 | 0.46914838 |
| 110 | DYRK3 | 0.46711715 |
| 111 | CAMK2D | 0.46205622 |
| 112 | STK4 | 0.46115204 |
| 113 | ILK | 0.43993376 |
| 114 | CSNK1G3 | 0.43240418 |
| 115 | CSNK1A1L | 0.43065327 |
| 116 | MAPK3 | 0.42827412 |
| 117 | KDR | 0.42726356 |
| 118 | TAOK2 | 0.42050296 |
| 119 | TYRO3 | 0.41584792 |
| 120 | PRKD1 | 0.40809157 |
| 121 | JAK2 | 0.40448523 |
| 122 | MAP4K2 | 0.40413351 |
| 123 | CDK9 | 0.40328079 |
| 124 | BRAF | 0.40059494 |
| 125 | MST4 | 0.40011845 |
| 126 | MAPKAPK5 | 0.38520413 |
| 127 | AKT2 | 0.38394157 |
| 128 | MAP2K4 | 0.38156101 |
| 129 | MAP2K3 | 0.37874345 |
| 130 | MOS | 0.37557118 |
| 131 | PIK3CA | 0.36897089 |
| 132 | NEK1 | 0.36896715 |
| 133 | IKBKB | 0.35342049 |
| 134 | AURKA | 0.34335098 |
| 135 | RET | 0.34017839 |
| 136 | PRKAA1 | 0.33366090 |
| 137 | ROCK2 | 0.32628622 |
| 138 | PKN1 | 0.32076432 |
| 139 | PDPK1 | 0.32069152 |
| 140 | SCYL2 | 0.31221099 |
| 141 | TYK2 | 0.29975113 |
| 142 | NTRK2 | 0.29302320 |
| 143 | RPS6KA1 | 0.29127994 |
| 144 | DYRK2 | 0.26688776 |
| 145 | BMX | 0.26368681 |
| 146 | BCR | 0.26318116 |
| 147 | EPHA2 | 0.26023176 |
| 148 | MAP3K2 | 0.24045785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66389524 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.55809524 |
| 3 | * Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.34091904 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21783428 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11299865 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.82339731 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.76581158 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.66860535 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56451564 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53481261 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.53273564 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.49252144 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45164745 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.44905315 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.31714119 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.24442686 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20033753 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.16503230 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01789398 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.97538737 |
| 21 | * Fatty acid elongation_Homo sapiens_hsa00062 | 1.92519646 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89120360 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87855509 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80840857 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79148459 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78286132 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72788426 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55117759 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50274167 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50110697 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.46450320 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43936183 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42156617 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39162880 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38867431 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37129077 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36355600 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.30075093 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28926280 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27044159 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26139038 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22957598 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.22902184 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19695958 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16428129 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11201491 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09282789 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08855980 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06080501 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.04787737 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04727503 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04712454 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04138398 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99591476 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97274458 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.94613822 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.92647764 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91632002 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86100469 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83925252 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78841843 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76538681 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71122755 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65955151 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65298556 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64716559 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63103242 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62180268 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59204366 |
| 70 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53205306 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.45404387 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44710457 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39379509 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26263506 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26129376 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26114728 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25825061 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25115615 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19524251 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.18186182 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17475271 |
| 82 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.17469810 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15918321 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.14625872 |
| 85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.14374527 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.12757792 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12305528 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09072900 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.07860155 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07017591 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.05908652 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05202393 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03007198 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.02175598 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.02126778 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01806006 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00453108 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | -0.1379480 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1331322 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1287829 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.1272367 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1248073 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1223007 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1080670 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1038357 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0970362 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0921562 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0771792 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0768669 |
| 110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0350172 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0347016 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.0278541 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | -0.0250770 |

